Close

UTHR Financial Facts

Net product sales: 408.2M
Net income per diluted common share (in dollars per share): 3.5
See Full Income Statement

Accumulated other comprehensive loss: -16.8M
Property, plant and equipment, net: 488.4M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 5/1/24 EPS Growth Rate +19.1%
Average EPS % Beat Rate +6.1% Revenue Growth Rate +22.7%
Average % Move 1-Wk after EPS -0.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/28/10 Q310 $0.66$0.54 +$0.12N/AN/A N/A Details
2/15/11 Q410 $1.27$0.62 +$0.65$166.5M$174.87M N/A Details
4/28/11 Q111 $1.29$0.64 +$0.65$165.6M$178.02M N/A Details
7/28/11 Q211 $1.49$0.53 +$0.96$183.75M$180.84M N/A Details
10/27/11 Q311 $1.65$0.73 +$0.92$201.7M$194.77M N/A Details
2/14/12 Q411 $0.79$0.87 -$0.08$195.2M$204.81M N/A Details
4/26/12 Q112 $1.32$0.93 +$0.39$204.2M$203.91M N/A Details
7/26/12 Q212 $1.34$1.12 +$0.22$225.6M$213.33M N/A Details